drugset / Trial / NCT02492412

Efficacy and Safety of HE10 for Dry Eye Syndrome

NCT02492412

Phase 3 Completed 101 enrolled Huons Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of HE10 eye drop for the patients with moderate to severe dry eye syndrome.

Timeline

Start
2013-05
Primary completion
2014-07
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cyclosporine Peptide 0.05 % Other
Subject HE10 Unknown Other

Indications